AS (3n-2) -Inclisiran

Inclisiran AS (3n-2) is a modified antisense variant of the siRNA therapeutic Inclisiran, incorporating a 2 bp spacer and three random nucleotide sites. Like its parent molecule, it is designed to target PCSK9 mRNA, facilitating its degradation and supporting research into lowering LDL cholesterol in both cellular and animal models.